Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CENTENE CORPORATION

(CNC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Centene : Signs Multi-Year Sponsorship Deal With Charlotte FC Major League Soccer Expansion Team

10/20/2021 | 12:44pm EST


ę MT Newswires 2021
All news about CENTENE CORPORATION
12/06Centene Corporation's 2022 Financial Guidance And Investor Day Event On December 10, 20..
PR
11/16Centene Arizona Subsidiaries Awarded Contract Expansion to Continue Serving Arizonans w..
PR
11/15CENTENE : 2021 Q3 Fact Sheet (PDF)
PU
11/15Centurion Health Begins Correctional Health Contract for Missouri Department of Correct..
CI
11/10Centene To Present At Wolfe Research Virtual Healthcare Conference
PR
11/05ETF PREVIEW : ETFs, Futures Pointing Higher as Wall Street Looks Ahead to October Nonfarm ..
MT
11/05Magellan Health Reports Lower Adjusted Q3 Profit while Revenue Rises
MT
11/04Centene To Present At Credit Suisse 30th Annual Healthcare Conference
PR
11/03Centene Corp Looks Forward to Ongoing Engagement with Politan Capital
CI
11/03Health Care Up After CVS Earnings -- Health Care Roundup
DJ
More news
Analyst Recommendations on CENTENE CORPORATION
More recommendations
Financials (USD)
Sales 2021 126 B - -
Net income 2021 1 196 M - -
Net Debt 2021 8 825 M - -
P/E ratio 2021 36,6x
Yield 2021 -
Capitalization 42 829 M 42 829 M -
EV / Sales 2021 0,41x
EV / Sales 2022 0,36x
Nbr of Employees 71 300
Free-Float 96,0%
Chart CENTENE CORPORATION
Duration : Period :
Centene Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CENTENE CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 73,40 $
Average target price 84,22 $
Spread / Average Target 14,7%
EPS Revisions
Managers and Directors
Michael F. Neidorff Chairman & Chief Executive Officer
Brent Davis Layton President & Chief Operating Officer
Andrew Lynn Asher Chief Financial Officer & Executive Vice President
Mary V. Mason Chief Medial Officer & Senior Vice President
Ken Yamaguchi Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
CENTENE CORPORATION22.27%42 829
UNITEDHEALTH GROUP32.52%437 707
ANTHEM, INC.25.70%99 814
CIGNA CORPORATION-0.76%68 927
HUMANA INC.5.42%55 657
MOLINA HEALTHCARE, INC.36.89%17 002